Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| RIGEL PHARMACEUTICALS INC | 282,017 | reported | 17 Feb 2026 | tx 73+12,704,360−510,478 |
1 purchase reported after at least 12 months of silence — most recent on 09 Jun 2022.
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 17 Feb 2026 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 53,915 | 0.00 USD | |
| 10 Feb 2026 | TAX_WITHHOLDING | RIGEL PHARMACEUTICALS INC | 7,607 | 34.62 USD | |
| 02 Feb 2026 | TAX_WITHHOLDING | RIGEL PHARMACEUTICALS INC | 14,110 | 36.01 USD | |
| 26 Jan 2026 | TAX_WITHHOLDING | RIGEL PHARMACEUTICALS INC | 35,424 | 37.00 USD | |
| 26 Jan 2026 | EXERCISE | RIGEL PHARMACEUTICALS INC | 40,000 | 27.40 USD | |
| 26 Jan 2026 | EXERCISE | RIGEL PHARMACEUTICALS INC | 40,000 | 27.40 USD | |
| 26 Jan 2026 | TAX_WITHHOLDING | RIGEL PHARMACEUTICALS INC | 35,211 | 37.00 USD | |
| 26 Jan 2026 | EXERCISE | RIGEL PHARMACEUTICALS INC | 40,000 | 0.00 USD | deriv |
| 26 Jan 2026 | EXERCISE | RIGEL PHARMACEUTICALS INC | 40,000 | 0.00 USD | deriv |
| 15 Sept 2025 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 31,700 | 0.00 USD | deriv |
| 17 Mar 2025 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 30,000 | 0.00 USD | deriv |
| 17 Mar 2025 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 26,250 | 0.00 USD | deriv |
| 04 Feb 2025 | SALE | RIGEL PHARMACEUTICALS INC | 4,952 | 20.92 USD | |
| 05 Feb 2025 | SALE | RIGEL PHARMACEUTICALS INC | 4,400 | 21.93 USD | |
| 29 Jan 2025 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 42,300 | 0.00 USD | |
| 29 Jan 2025 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 63,400 | 0.00 USD | deriv |
| 24 Jan 2025 | TAX_WITHHOLDING | RIGEL PHARMACEUTICALS INC | 44,078 | 22.17 USD | |
| 24 Jan 2025 | EXERCISE | RIGEL PHARMACEUTICALS INC | 45,000 | 21.40 USD | |
| 24 Jan 2025 | TAX_WITHHOLDING | RIGEL PHARMACEUTICALS INC | 44,078 | 22.17 USD | |
| 24 Jan 2025 | EXERCISE | RIGEL PHARMACEUTICALS INC | 45,000 | 21.40 USD | |
| 24 Jan 2025 | EXERCISE | RIGEL PHARMACEUTICALS INC | 45,000 | 0.00 USD | deriv |
| 24 Jan 2025 | EXERCISE | RIGEL PHARMACEUTICALS INC | 45,000 | 0.00 USD | deriv |
| 25 Nov 2024 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 30,000 | 0.00 USD | deriv |
| 30 Aug 2024 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 32,500 | 0.00 USD | deriv |
| 28 Feb 2024 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 300,000 | 0.00 USD | deriv |